The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1177
ISSUE1177
March 1, 2004
An Injectable Hyaluronic Acid (Restylane) for Wrinkles
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
An Injectable Hyaluronic Acid (Restylane) for Wrinkles
March 1, 2004 (Issue: 1177)
An injectable gel of hyaluronic acid (Restylane) has been approved by the FDA for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Manufactured by Q-Med AB, a Swedish company, it has been used outside the US since...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.